ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies
ImpriMed has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in September 2026.
ImpriMed's investors include Plug and Play, Pear VC, Draper Associates, Sazze Partners, SBVA.
ImpriMed is headquartered in Mountain View, United States.
ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies
ImpriMed is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImpriMed — Funding & Investors." VCBacked, September 18, 2026, https://www.vcbacked.co/company/imprimed. Accessed October 17, 2026.
VCBacked. (2026). ImpriMed — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/imprimed
{{cite web |title=ImpriMed — Funding & Investors |url=https://www.vcbacked.co/company/imprimed |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated